INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  5. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  6. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  7. SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  8. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
AN
Abrahamsen Danielle NicoleChief Accounting Officer
CVLTCOMMVAULT SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$17K
119 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

13
LX
Lin XichenCHIEF SCIENTIFIC OFFICER
GPCRStructure Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$22K
400 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

13
RJ
Riley JanelChief Accounting Officer
NETCloudflare, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
140 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$109K
8,205 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

11
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$270K
4,630 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$105K
8,205 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
8,205 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

11
KZ
Katz ZacharyCLO and Head of Global Affairs
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$161K
10.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$396K
5,066 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

11
SS
Slocum Jeffrey ShannonDirector, Director, EVP and COO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$566K
16.1K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

11
MH
Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner
PACSPACS Group, Inc.
Open-market sale · 10b5-1 plan
SELL$3,005
67 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

10
TO
Tkach OxanaPRINCIPAL ACCOUNTING OFFICER
BLNDBlend Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
21.2K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

9
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$336K
60.0K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

9
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$332K
60.0K sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

9
OH
Oey Peter HenryChief Financial Officer
GRABGrab Holdings Ltd
Open-market sale · 10b5-1 plan
SELL$180K
50.0K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

9
AA
Ashish AroraDirector, Chief Executive Officer, 10% Owner
CRCTCricut, Inc.
Open-market sale · 10b5-1 plan
SELL$329K
60.0K sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

8
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$58K
718 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

8
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
3,282 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

8
KS
Kereere SuzanPresident, Global Markets
PYPLPayPal Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$205K
3,362 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

8
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$108K
1,358 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

8
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
3,282 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

8
TS
Tyagarajan SeshuChief Technology Officer
CADLCandel Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
7,000 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

8
DM
Doyle MittieChief Medical Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$20K
1,000 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

8
NE
Nonko EugeneDirector
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
3,282 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$254K
3,220 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
GP
Gallup PatriciaDirector, Chairman & Chief Admin Officer, 10% Owner
CNXNPC CONNECTION INC
Open-market sale · 10b5-1 plan
SELL$307K
3,922 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$30K
77 sh
Aug 19, 2026Aug 19, 2026
traded Aug 19, 2026
+0dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$30K
77 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

7
EM
Ellenbogen MichaelDirector
EVLVEvolv Technologies Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$451K
80.8K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

7
BM
Brosius MarkEVP & Chief Mfg and Supply Cha
ISRGINTUITIVE SURGICAL INC
Open-market sale · 10b5-1 plan
SELL$30K
77 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$168K
1,633 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$155K
1,477 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

6
SS
Schwartz SophiaChief Legal Officer, Secretary
NXDRNextdoor Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$6,286
2,500 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

6
GV
Gupta VikramSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$121K
1,167 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

5
HR
Hamady Robert RamseyChief Financial Officer
SMRNUSCALE POWER Corp
Open-market sale · 10b5-1 plan
SELL$0
0 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

4
WJ
Wetterwald JulienChief Technology Officer
WLTHWEALTHFRONT CORP
Open-market sale · 10b5-1 plan
SELL$140K
15.3K sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

4
HB
Hohl BenjaminCHIEF FINANCIAL OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
1,388 sh
Aug 17, 2026Aug 19, 2026
traded Aug 17, 2026
+2dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$9,941
96 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$18K
177 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$17K
164 sh
Aug 18, 2026Aug 19, 2026
traded Aug 18, 2026
+1dSEC Form 4

Evidence

Page 168 of 481
← PrevNext →